Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 1
1963 2
1964 4
1965 1
1968 1
1970 1
1972 1
1974 20
1975 43
1976 35
1977 23
1978 49
1979 43
1980 59
1981 46
1982 73
1983 69
1984 59
1985 42
1986 43
1987 134
1988 158
1989 194
1990 287
1991 275
1992 251
1993 263
1994 251
1995 318
1996 249
1997 237
1998 278
1999 322
2000 337
2001 399
2002 390
2003 357
2004 278
2005 303
2006 384
2007 376
2008 388
2009 300
2010 363
2011 350
2012 423
2013 386
2014 289
2015 294
2016 290
2017 234
2018 262
2019 142
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

9,715 results
Results by year
Filters applied: . Clear all
Page 1
Specific-pathogen-free Turkey model for reoviral arthritis.
Ngunjiri JM, et al. Vet Microbiol 2019. PMID 31383299
In this study, turkeys from a specific-pathogen-free (SPF) flock were evaluated for use as a turkey reoviral arthritis model. ...
In this study, turkeys from a specific-pathogen-free (SPF) flock were evaluated for use as a turkey reoviral arthritis …
Isolation of chicken astrovirus from specific pathogen-free chicken embryonated eggs.
Nuñez LF, et al. Poult Sci 2015. PMID 25805833 Free article.
Here, we describe the isolation, propagation, and pathological characteristics of chicken astrovirus (CAstV) in specific pathogen free (SPF) chicken embryonated eggs (CEE) from chickens with diarrhea and runting-stunting syndrome. ...
Here, we describe the isolation, propagation, and pathological characteristics of chicken astrovirus (CAstV) in specific pathogen
Myelopoiesis in experimentally contaminated specific-pathogen-free and germfree mice during oral administration of polymyxin.
Goris H, et al. Infect Immun 1985. PMID 2997040 Free PMC article.
Oral administration of polymyxin to specific-pathogen-free C3H/Law mice which with previously contaminated with gram-negative bacteria resulted in complete suppression of cecal gram-negative bacteria. ...The kinetic behavior of femoral and splenic CFU-GM in experimentally contaminated specific-pathogen-free and germfree mice was expressed as the in vivo sensitivity to the S-phase-specific cytostatic drug hydroxyurea, i.e., the hydroxyurea kill. ...
Oral administration of polymyxin to specific-pathogen-free C3H/Law mice which with previously contaminated with gram-ne …
The development of a specific pathogen free (SPF) barrier colony of marmosets (Callithrix jacchus) for aging research.
Ross CN, et al. Aging (Albany NY) 2017. PMID 29227963 Free PMC article.
A specific pathogen free (SPF) barrier colony of breeding marmosets (Callithrix jacchus) was established at the Barshop Institute for Longevity and Aging Studies. ...
A specific pathogen free (SPF) barrier colony of breeding marmosets (Callithrix jacchus) was established at the Barshop …
Evidence of porcine epidemic diarrhea virus (PEDV) shedding in semen from infected specific pathogen-free boars.
Gallien S, et al. Vet Res 2018. PMID 29368629 Free PMC article.
The aim of the study was to determine if PEDV could be detected in semen from infected specific pathogen-free (SPF) boars inoculated with a PEDV US non-InDel strain suggesting venereal transmission may occur. ...
The aim of the study was to determine if PEDV could be detected in semen from infected specific pathogen-free (SPF) boa …
The specific pathogen-free human: a new frontier in oral infectious disease research.
Taubman MA, et al. Adv Dent Res 1989 - Review. PMID 2532515
We propose that advances in oral health research will lead to control of oral infections by altering the indigenous microflora to create a specific pathogen-free human. ...Several approaches to produce a specific pathogen-free human include: (1) introduction of individual or collective moieties which inhibit detrimental interactions on a genetic and molecular level; (2) genetic modification of salivary flow and protein composition by use of transgenic techniques; (3) therapeutic replacement with altered bacterial strains; (4) alteration of host immune responses to produce specific isotype immunity at the most appropriate time in the ontogeny of the oral environment; (5) production of isotype and/or antigen-specific regulatory molecules at the most appropriate time in development; (6) use of synthetic vaccines; (7) genetic alteration or replacement of cells with defective protective capabilities; and (8) use of anti-idiotype vaccines....
We propose that advances in oral health research will lead to control of oral infections by altering the indigenous microflora to create a …
9,715 results
Jump to page
Feedback